Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gel-e FLEX
- Development stage
- Unknown
- Lead developer
- Medcura
- Administration
- Topical
01
Overview
Gel-e FLEX is a flowable hemostatic medical device developed by Medcura (formerly gel-e Inc.). It is indicated for the local management of minor bleeding, including lacerations and abrasions, and received FDA 510(k) clearance for over-the-counter (OTC) use in 2018. The product utilizes a proprietary, hydrophobically modified chitosan chemistry to create a rapid physical seal at the site of injury, effectively stopping bleeding. It is designed for ease of use by healthcare professionals, caregivers, and patients to manage external wounds through a flowable gel application that conforms to the wound site.
- Brand names
- Gel-e FLEX
Beyond the preview
Go deeper on Gel-e FLEX.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Gel-e FLEX.